Driving Natural Killer Cell Immunotherapy in the Castration Resistant Prostate Cancer Setting with Novel Tri-Specific Killer Engager Molecules
|Effective start/end date||8/1/20 → 7/31/24|
- U.S. DEPARTMENT OF DEFENSE
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.